About Careers MedBlog Contact us

Chile Researchers Develop Vaccine for Common Respiratory Virus in Children

by Dr. Trupti Shirole on January 9, 2016 at 10:52 PM
Font : A-A+

 Chile Researchers Develop Vaccine for Common Respiratory Virus in Children

The respiratory syncytial virus (RSV) commonly causes lung and respiratory tract infections in children. It kills or forces the hospitalization of thousands of babies around the world each year. Mayo Clinic researchers suggest that the virus is so common that most children have been infected with it by age two.

Researchers in Chile revealed that they have developed the first vaccine against the RSV. The team said, "After clinical trials can be held it hopes to market the vaccine against so-called RSV in four or five years."


In temperate climates like that of Chile, there are annual epidemics of the virus in winter.

After ten years of work the vaccine was developed by a team led by Dr. Alexis Kalergis at the Millennium Institute on Immunology and Immunotherapy.

"This virus is very harmful and costly for Chilean society and the vast majority of countries," said Kalergis.

Kalergis further added, "The vaccine has been successful in tests with animals and now the team is ready for clinical trials on people. Assuming we have financing and the results are favorable, we could have a vaccine in four or five years."

Source: AFP


Recommended Reading

Latest Research News

Tackling Football at Young Age: A Risk for Brain Decline Later
Injury to the white matter explains why football players are at an increased risk for cognitive and behavioral problems later in life.
Frozen Frontier: Humans Leave a Unique Microbial Mark on Mount Everest
Located at the South Col, the rocky area between Mount Everest and Lhotse serves as the final campsite for climbers as well as a frozen legacy of hardy microbes.
How Does Protein Synthesis in Diarrhea Causing Parasite Work?
The new finding is found to be valuable for screening specific medications and treatment against Giardia and other protozoan parasites.
Unlocking the Potential of CRISPR for Reversing Vision Loss
New CRISPR genome-editing strategy was found to have a positive impact in the treatment of inherited retinal diseases such as retinitis pigmentosa.
 New RT-qPCR Kit Detects Influenza, COVID-19
H3N2 Influenza: The newly developed RT-qPCR Kit to identify influenza, COVID-19 and respiratory virus has got approval from ICMR.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Chile Researchers Develop Vaccine for Common Respiratory Virus in Children Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests